SCHEMBL2890759

SCHEMBL2890759

CCCCOc1cc(C=O)ccc1O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.73
TRIM24 O15164 1/20 0.60
HPGD P15428 1/20 0.60
ALDH5A1 P51649 1/20 0.60
ABAT P80404 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
TRIM33 Q9UPN9 1/20 0.60
STK17B O94768 3/20 0.54
FDPS P14324 1/20 0.53
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
SMPD1 P17405 1/20 0.49
TOP2A P11388 1/20 0.49
AOX1 Q06278 1/20 0.47
PRKCE Q02156 1/20 0.47
PRKCQ Q04759 1/20 0.47
PRKCD Q05655 1/20 0.47
RAB9A P51151 2/20 0.47
KDM4E B2RXH2 1/20 0.47
PTGS2 P35354 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14323012 0.95 ALDH1A1 (0.71) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL14856076 0.94 ALDH1A1 (0.69) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL11503669 0.94 ALDH1A1 (0.69) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL14790874 0.93 ALDH1A1 (0.64) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL972755 0.92 ALDH1A1 (0.76) ALDH1A1TRIM24HPGDALDH5A1ABAT
Protocatechualdehyde SCHEMBL6675611 0.88 ALDH1A1 (0.69) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL1425314 0.87 ALDH1A1 (0.60) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL14787812 0.86 ALDH1A1 (0.68) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL1098158 0.86 ALDH1A1 (0.67) ALDH1A1TRIM24HPGDALDH5A1ABAT
Vanillin SCHEMBL906447 0.85 ALDH1A1 (0.71) ALDH1A1TRIM24HPGDALDH5A1ABAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111777746-B Halogen-free flame-retardant epoxy resin composition, molding compound product, preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2020-12-11 CN claimed
CN-111793091-A Halogen-free flame-retardant epoxy resin precursor, composition, molding compound product, preparation method and application 中国科学院宁波材料技术与工程研究所 2020-10-20 CN claimed
CN-111777746-A Halogen-free flame-retardant epoxy resin composition, molding compound product, preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2020-10-16 CN claimed
US-20180037843-A1 PERFUME SYSTEMS PROCTER & GAMBLE (US) 2018-02-08 US claimed
EP-2723841-B1 PERFUME SYSTEMS PROCTER & GAMBLE (US) 2017-01-04 EP claimed
US-20160186093-A1 PERFUME SYSTEMS PROCTER & GAMBLE (US) 2016-06-30 US claimed
US-9309487-B2 Perfume systems THE PROCTER & GAMBLE COMPANY (US) 2016-04-12 US claimed
US-20140378360-A1 PERFUME SYSTEMS PROCTER & GAMBLE (US) 2014-12-25 US claimed
EP-2723841-A1 PERFUME SYSTEMS The Procter and Gamble Company (US) 2014-04-30 EP claimed
CN-101679225-B Method for the synthesis of (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl]-2-methoxy-acrylic acid GALDERMA RES & DEV 2014-04-02 CN claimed
WO-2012177357-A1 PERFUME SYSTEMS THE PROCTER & GAMBLE COMPANY (US) 2012-12-27 WO claimed
US-20120329696-A1 PERFUME SYSTEMS PROCTER & GAMBLE COMPANY, THE 2012-12-27 US claimed
EP-2146954-B1 METHOD FOR THE SYNTHESIS OF (Z)-3-[2-BUTOXY-3'-(3-HEPTYL-1-METHYL-UREIDO)-BIPHENYL-4-YL]-2-METHOXY-ACRYLIC ACID GALDERMA RES & DEV (FR) 2012-10-31 EP claimed
US-20100286430-A1 METHOD FOR THE SYNTHESIS OF (Z)-3-[2-BUTOXY-3'-(3-HEPTYL-1-METHYL-UREIDO)-BIPHENYL-4-YL]-2-METHOXY-ACRYLIC ACID GALDERMA RESEARCH & DEVELOPMENT (FR) 2010-11-11 US claimed
EP-2146954-A2 METHOD FOR THE SYNTHESIS OF (Z)-3-[2-BUTOXY-3'-(3-HEPTYL-1-METHYL-UREIDO)-BIPHENYL-4-YL]-2-METHOXY-ACRYLIC ACID Galderma Research & Development (FR) 2010-01-27 EP claimed
WO-2008139121-A2 METHOD FOR THE SYNTHESIS OF (Z)-3-[2-BUTOXY-3'-(3-HEPTYL-1-METHYL-UREIDO)-BIPHENYL-4-YL]-2-METHOXY-ACRYLIC ACID GALDERMA RESEARCH & DEVELOPMENT (FR) 2008-11-20 WO claimed
EP-0709361-B1 Process for the preparation of isovanilline RHODIA CHIMIE SA (FR) 1999-02-03 EP claimed
US-5786516-A Process for the preparation of isovanillin RHONE-POULENC CHIMIE (FR) 1998-07-28 US claimed
US-5648552-A Process for the preparation of isovanillin RHONE-POULENC CHIMIE (FR) 1997-07-15 US claimed
EP-0709361-A1 Process for the preparation of isovanilline RHONE-POULENC CHIMIE (FR) 1996-05-01 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037843-A1 PERFUME SYSTEMS TRPA1, PORCN, PLIN5 ALDH1A1 1292/4885TRIM24 4410/4885HPGD 400/4885
US-20100286430-A1 METHOD FOR THE SYNTHESIS OF (Z)-3-[2-BUTOXY-3'-(3-HEPTYL-1-METHYL-UREIDO)-BIPHENYL-4-YL]-2-METHOXY-ACRYLIC ACID AZI2, UGT1A6, UGT1A3 ALDH1A1 133/4885TRIM24 2643/4885HPGD 614/4885
US-20120329696-A1 PERFUME SYSTEMS TRPA1, PORCN, PLIN5 ALDH1A1 1292/4885TRIM24 4410/4885HPGD 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.